BIOMAT Database Logo BIOMAT Database Logo

Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal alpha and beta subunits. 2003

G Sébastien Apcher, and Sylvia Heink, and Daniela Zantopf, and Peter-M Kloetzel, and Hans-P Schmid, and R John Mayer, and Elke Krüger
Humboldt Universität zu Berlin, Universitätsklinikum Charité, Institut für Biochemie, Germany.

The human immunodeficiency virus-1 (HIV-1) Tat protein was previously reported to compete the association of PA28 regulator with the alpha rings of the 20S proteasome and to inhibit its peptidase activity. However, the distinct interaction sites within the proteasome complex remained to be determined. Here we show that HIV-1 Tat binds to alpha4 and alpha7, six beta subunits of the constitutive 20S proteasome and the interferon-gamma-inducible subunits beta2i and beta5i. A Tat-proteasome interaction can also be demonstrated in vivo and leads to inhibition of proteasomal activity. This indicates that Tat can modulate or interfere with cellular proteasome function by specific interaction with distinct proteasomal subunits.

UI MeSH Term Description Entries
D009097 Multienzyme Complexes Systems of enzymes which function sequentially by catalyzing consecutive reactions linked by common metabolic intermediates. They may involve simply a transfer of water molecules or hydrogen atoms and may be associated with large supramolecular structures such as MITOCHONDRIA or RIBOSOMES. Complexes, Multienzyme
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015696 Gene Products, tat Trans-acting transcription factors produced by retroviruses such as HIV. They are nuclear proteins whose expression is required for viral replication. The tat protein stimulates LONG TERMINAL REPEAT-driven RNA synthesis for both viral regulatory and viral structural proteins. Tat stands for trans-activation of transcription. tat Gene Products,tat Protein,Gene Product, tat,tat Gene Product
D015853 Cysteine Proteinase Inhibitors Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. Acid Cysteine Proteinase Inhibitor,Cysteine Protease Inhibitor,Cysteine Protease Inhibitors,Cysteine Proteinase Antagonist,Cysteine Proteinase Antagonists,Cysteine Proteinase Inhibitor,Cysteine Proteinase Inhibitors, Endogenous,Cysteine Proteinase Inhibitors, Exogenous,alpha-Cysteine Protease Inhibitor,Acid Cysteine Proteinase Inhibitors,alpha-Cysteine Protease Inhibitors,Antagonist, Cysteine Proteinase,Antagonists, Cysteine Proteinase,Inhibitor, Cysteine Protease,Inhibitor, Cysteine Proteinase,Inhibitor, alpha-Cysteine Protease,Inhibitors, Cysteine Protease,Inhibitors, Cysteine Proteinase,Inhibitors, alpha-Cysteine Protease,Protease Inhibitor, Cysteine,Protease Inhibitor, alpha-Cysteine,Protease Inhibitors, Cysteine,Protease Inhibitors, alpha-Cysteine,Proteinase Antagonist, Cysteine,Proteinase Antagonists, Cysteine,Proteinase Inhibitor, Cysteine,Proteinase Inhibitors, Cysteine,alpha Cysteine Protease Inhibitor,alpha Cysteine Protease Inhibitors
D046988 Proteasome Endopeptidase Complex A large multisubunit complex that plays an important role in the degradation of most of the cytosolic and nuclear proteins in eukaryotic cells. It contains a 700-kDa catalytic sub-complex and two 700-kDa regulatory sub-complexes. The complex digests ubiquitinated proteins and protein activated via ornithine decarboxylase antizyme. 20S Proteasome,Ingensin,Macropain,Macroxyproteinase,Multicatalytic Endopeptidase Complex,Multicatalytic Proteinase,Prosome,Proteasome,Complex, Multicatalytic Endopeptidase,Complex, Proteasome Endopeptidase,Endopeptidase Complex, Multicatalytic,Endopeptidase Complex, Proteasome,Proteasome, 20S,Proteinase, Multicatalytic

Related Publications

G Sébastien Apcher, and Sylvia Heink, and Daniela Zantopf, and Peter-M Kloetzel, and Hans-P Schmid, and R John Mayer, and Elke Krüger
Human immunodeficiency virus-1 Nef protein interacts with Tat and enhances HIV-1 gene expression.
July 2003, FEBS letters,
G Sébastien Apcher, and Sylvia Heink, and Daniela Zantopf, and Peter-M Kloetzel, and Hans-P Schmid, and R John Mayer, and Elke Krüger
Triptolide inhibits human immunodeficiency virus type 1 replication by promoting proteasomal degradation of Tat protein.
October 2014, Retrovirology,
G Sébastien Apcher, and Sylvia Heink, and Daniela Zantopf, and Peter-M Kloetzel, and Hans-P Schmid, and R John Mayer, and Elke Krüger
Rat alpha-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex.
November 2000, Journal of neurochemistry,
G Sébastien Apcher, and Sylvia Heink, and Daniela Zantopf, and Peter-M Kloetzel, and Hans-P Schmid, and R John Mayer, and Elke Krüger
Human immunodeficiency virus-1 protein tat and methamphetamine interactions.
August 2006, Annals of the New York Academy of Sciences,
G Sébastien Apcher, and Sylvia Heink, and Daniela Zantopf, and Peter-M Kloetzel, and Hans-P Schmid, and R John Mayer, and Elke Krüger
A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator.
June 1990, Science (New York, N.Y.),
G Sébastien Apcher, and Sylvia Heink, and Daniela Zantopf, and Peter-M Kloetzel, and Hans-P Schmid, and R John Mayer, and Elke Krüger
Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity.
June 2007, Neurobiology of disease,
G Sébastien Apcher, and Sylvia Heink, and Daniela Zantopf, and Peter-M Kloetzel, and Hans-P Schmid, and R John Mayer, and Elke Krüger
Human immunodeficiency virus type 1 matrix protein interacts with cellular protein HO3.
February 1998, Journal of virology,
G Sébastien Apcher, and Sylvia Heink, and Daniela Zantopf, and Peter-M Kloetzel, and Hans-P Schmid, and R John Mayer, and Elke Krüger
Human immunodeficiency virus type 1 TAT protein activates B lymphocytes.
August 1997, Biochemical and biophysical research communications,
G Sébastien Apcher, and Sylvia Heink, and Daniela Zantopf, and Peter-M Kloetzel, and Hans-P Schmid, and R John Mayer, and Elke Krüger
Angiogenic properties of human immunodeficiency virus type 1 Tat protein.
May 1995, Proceedings of the National Academy of Sciences of the United States of America,
G Sébastien Apcher, and Sylvia Heink, and Daniela Zantopf, and Peter-M Kloetzel, and Hans-P Schmid, and R John Mayer, and Elke Krüger
Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits.
January 2005, Neuroscience,
Copied contents to your clipboard!